|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CONDUCTUS INC, 10-Q, EX-10.43, 2000-11-14 |
Next: WATSON PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 19,752
<SECURITIES> 0
<RECEIVABLES> 599
<ALLOWANCES> 0
<INVENTORY> 2,330
<CURRENT-ASSETS> 22,826
<PP&E> 10,580
<DEPRECIATION> 8,638
<TOTAL-ASSETS> 24,991
<CURRENT-LIABILITIES> 3,189
<BONDS> 0
0
0
<COMMON> 2
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 24,991
<SALES> 0
<TOTAL-REVENUES> 589
<CGS> 0
<TOTAL-COSTS> 4,292
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 49
<INCOME-PRETAX> (3,377)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,377)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,377)
<EPS-BASIC> (0.22)
<EPS-DILUTED> (0.22)
</TABLE>
|
|